Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Steris
(NYSE:STE)
Intraday
$225.99
15.90
[7.57%]
After-Hours
$225.99
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$225.99
15.90
[7.57%]
At close: May 9
$225.99
0
[0.00%]
After Hours: 4:06PM EDT
Get Report
Watch
Q4 2024 Earnings were released on Wed May 8th, after the market close
Today's conference call ended over 16 hours ago
Click to view past webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Steris Stock (NYSE:STE)
Steris Stock (NYSE: STE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, May 09, 2024
JMP Securities Reiterates Market Outperform on Steris, Maintains $265 Price Target
Benzinga Newsdesk
-
6 hours ago
STERIS shares are trading higher after the company reported better-than-expected Q4 financial results. The company announced planned restructuring of its healthcare surgical business in Europe.
Benzinga Newsdesk
-
10 hours ago
Wednesday, May 08, 2024
STERIS Expects FY25 As Reported Revenue From Continuing Operations To Increase 6.5%-7.5%; Adjusted EPS From Continuing Operations Of $9.05 - $9.25 (Est $9.33)
Benzinga Newsdesk
-
1 day ago
STERIS Plans Restructuring Of Healthcare Surgical Business In Europe, Other Actions
Benzinga Newsdesk
-
1 day ago
Steris Q4 2024 Adj EPS $2.58 Beats $2.35 Estimate, Sales $1.419B Beat $1.411B Estimate
Benzinga Newsdesk
-
1 day ago
Friday, April 12, 2024
Needham Reiterates Hold on Steris
Benzinga Newsdesk
-
Apr 12, 2024, 4:39AM
Thursday, April 11, 2024
STERIS shares are trading higher after the company entered a deal to divest its dental segment to Peak Rock Capital for $787.5 million.
Benzinga Newsdesk
-
Apr 11, 2024, 7:08AM
STERIS Enters Definitive Deal To Divest Its Dental Segment To Peak Rock Capital For $787.5M
Benzinga Newsdesk
-
Apr 11, 2024, 6:59AM
Friday, February 09, 2024
What 4 Analyst Ratings Have To Say About Steris
Benzinga Insights
-
Feb 9, 2024, 2:01PM
Stephens & Co. Reiterates Overweight on Steris, Maintains $250 Price Target
Benzinga Newsdesk
-
Feb 9, 2024, 1:12PM
Thursday, February 08, 2024
JMP Securities Reiterates Market Outperform on Steris, Maintains $265 Price Target
Benzinga Newsdesk
-
Feb 8, 2024, 2:23PM
STERIS shares are trading lower after the company reported Q3 financial results.
Benzinga Newsdesk
-
Feb 8, 2024, 10:39AM
Wednesday, February 07, 2024
Recap: Steris Q3 Earnings
Benzinga Insights
-
Feb 7, 2024, 4:40PM
STERIS Now Expects FY24 As Reported Revenue To Increase 10-11%, Up From Previous Expectations Of 9-10%; Revises Adjusted EPS Outlook From $8.60-$8.80 To $8.60-$8.70 (Est $8.67)
Benzinga Newsdesk
-
Feb 7, 2024, 4:37PM
Steris Q3 Sales $1.40B Beat $1.35B Estimate
Benzinga Newsdesk
-
Feb 7, 2024, 4:32PM
Steris Q3 Adj EPS $2.22 Beats $2.17 Estimate
Benzinga Newsdesk
-
Feb 7, 2024, 4:31PM
Earnings Scheduled For February 7, 2024
Benzinga Insights
-
Feb 7, 2024, 5:13AM
Tuesday, February 06, 2024
Earnings Outlook For Steris
Benzinga Insights
-
Feb 6, 2024, 1:02PM
Keybanc Initiates Coverage On Steris with Overweight Rating, Announces Price Target of $253
Benzinga Newsdesk
-
Feb 6, 2024, 7:14AM
Thursday, December 21, 2023
Steris Exceeds Expectations with Strong Performance, Driving Profits and Rewarding Investors
Benzinga Insights
-
Dec 21, 2023, 10:05AM
Monday, December 04, 2023
Analyst Expectations for Steris's Future
Benzinga Insights
-
Dec 4, 2023, 10:00AM
Morgan Stanley Maintains Equal-Weight on Steris, Lowers Price Target to $215
Benzinga Newsdesk
-
Dec 4, 2023, 8:12AM
Thursday, November 09, 2023
JMP Securities Reiterates Market Outperform on Steris, Maintains $265 Price Target
Benzinga Newsdesk
-
Nov 9, 2023, 12:25PM
Wednesday, November 08, 2023
STERIS shares are trading lower after the company reported Q2 financial results and issued FY24 EPS guidance.
Benzinga Newsdesk
-
Nov 8, 2023, 10:18AM
Tuesday, November 07, 2023
STERIS Sees FY24 EPS $8.60-$8.80 Vs $8.75 Est.; Revenue Growth Of 9%-10%
Benzinga Newsdesk
-
Nov 7, 2023, 4:49PM
Recap: Steris Q2 Earnings
Benzinga Insights
-
Nov 7, 2023, 4:40PM
Steris Q2 EPS $2.03 Beats $2.01 Estimate, Sales $1.34B Beat $1.30B Estimate
Benzinga Newsdesk
-
Nov 7, 2023, 4:30PM
Earnings Scheduled For November 7, 2023
Benzinga Insights
-
Nov 7, 2023, 6:34AM
Thursday, October 26, 2023
Piper Sandler Maintains Neutral on Steris, Lowers Price Target to $215
Benzinga Newsdesk
-
Oct 26, 2023, 12:20PM
Monday, September 25, 2023
Analyst Ratings for Steris
Benzinga Insights
-
Sep 25, 2023, 10:00AM
Stephens & Co. Reiterates Overweight on Steris, Maintains $250 Price Target
Benzinga Newsdesk
-
Sep 25, 2023, 9:48AM
Friday, September 01, 2023
Expert Ratings for Steris
Benzinga Insights
-
Sep 1, 2023, 12:00PM
JMP Securities Maintains Market Outperform on Steris, Raises Price Target to $265
Benzinga Newsdesk
-
Sep 1, 2023, 8:25AM
Thursday, August 03, 2023
Morgan Stanley Maintains Equal-Weight Rating for Steris: Here's What You Need To Know
Benzinga Insights
-
Aug 3, 2023, 1:00PM
Morgan Stanley Maintains Equal-Weight on Steris, Raises Price Target to $225
Benzinga Newsdesk
-
Aug 3, 2023, 11:44AM
Keybanc Maintains Overweight on Steris, Raises Price Target to $258
Benzinga Newsdesk
-
Aug 3, 2023, 4:40AM
Wednesday, August 02, 2023
What 7 Analyst Ratings Have To Say About Steris
Benzinga Insights
-
Aug 2, 2023, 5:00PM
JMP Securities Reiterates Market Outperform on Steris, Maintains $240 Price Target
Benzinga Newsdesk
-
Aug 2, 2023, 9:46AM
STERIS Plc Shares Resume Trade
Happy Mohamed
-
Aug 2, 2023, 9:42AM
STERIS Plc Shares Halted On Circuit Breaker To The Downside, Stock Now Up 5.32%
Happy Mohamed
-
Aug 2, 2023, 9:38AM
Tuesday, August 01, 2023
STERIS Sees FY24 Revenue Up 9-10% Vs 7-8% Prior
Benzinga Newsdesk
-
Aug 1, 2023, 4:37PM
Steris Q1 EPS $2.00 Beats $1.86 Estimate, Sales $1.28B Beat $1.19B Estimate
Benzinga Newsdesk
-
Aug 1, 2023, 4:33PM
STERIS Raises Dividend From $0.47 To $0.52
Benzinga Newsdesk
-
Aug 1, 2023, 4:29PM
Earnings Scheduled For August 1, 2023
Benzinga Insights
-
Aug 1, 2023, 4:06AM
Wednesday, July 26, 2023
STERIS Increases Quarterly Dividend From $0.47 To $0.52/Share
Bill Haddad
-
Jul 26, 2023, 5:12PM
Tuesday, July 25, 2023
Keybanc Maintains Overweight on Steris, Raises Price Target to $254
Benzinga Newsdesk
-
Jul 25, 2023, 4:11AM
Monday, July 17, 2023
What 5 Analyst Ratings Have To Say About Steris
Benzinga Insights
-
Jul 17, 2023, 1:00PM
Stephens & Co. Maintains Overweight on Steris, Raises Price Target to $250
Benzinga Newsdesk
-
Jul 17, 2023, 11:56AM
Tuesday, June 20, 2023
Becton Dickinson Banks $540M With Surgical Unit Sale, 360 Employees To Join Steris
Nabaparna Bhattacharya
-
Jun 20, 2023, 12:08PM
BD To Sell Surgical Instrumentation Platform To STERIS For $540M
Benzinga Newsdesk
-
Jun 20, 2023, 8:03AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch